Portugal - Antiarrhythmic Medicine Use
Since 2014, Portugal Antiarrhythmic Medicine Use decreased by 4.1% year on year. With 4.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 10 comparing other countries in Antiarrhythmic Medicine Use. Portugal is overtaken by Estonia, which was ranked number 9 with 5.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Iceland at 4.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Slovakia lead the ranking with 10.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.9% compared to 2018. Czech Republic, Belgium and Italy respectively ranked number 2, 3 and 4 in this ranking. South Korea recorded the best 5 years average growth at +7% per year, while Chile recorded the worst performance at -4.1% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 4.70 |
2018 | 5.00 |
2017 | 5.20 |
2016 | 5.30 |
2015 | 5.60 |
How does Portugal rank in Antiarrhythmic Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Slovakia
|
11 | 2019 | +3.9 % | +1.4 % | View data | |
2 |
#2
Czech Republic
|
9 | 2019 | +2.3 % | +1.9 % | View data | |
9 |
#9
Estonia
|
6 | 2019 | -9.5 % | -3.8 % | View data | |
10 |
#10
Portugal
|
5 | 2019 | -6.0 % | -4.1 % | View data | |
11 |
#11
Iceland
|
5 | 2019 | +0.0 % | +2.4 % | View data |